Quantum量子訊息有限公司

NAD-based Anti-Aging Market

完整報告名稱與涵蓋範圍
NAD-based Anti-Aging Market Size, Share & Trends Analysis Report By Precursor, By Product Type (Supplements (Oral NAD Dietary Supplements, Topical NAD Supplements (Creams, Serums, Lip Creams, Eye Creams)) Therapeutic Products (NAD Nasal Spray, and NAD injections/NAD IV)), Type of Aging, Distribution Channel, Region, And Segment Forecasts, 2025-2034

報告摘要

With a 2024 valuation of USD 252.0 Million, the global NAD-based Anti-Aging Market is set to progress to USD 884.0 Million by 2034, demonstrating a CAGR of 13.5% during the 2025–2034 forecast window. At its core, NAD-based Anti-Aging pertains to landscape are risingly turning to these solutions to meet contemporary demands. Several factors contribute to this trajectory, including heightened appetite for next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives. From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities. Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region set to deliver the strongest growth trajectory through the forecast period, bolstered by demographic shifts and policy support. The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion. Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.

授權報價

Single User PDF$4,500 USD
Global Site License PDF$9,500 USD

目錄 Table of Contents

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global NAD-based Anti-Aging Market Snapshot Chapter 4. Global NAD-based Anti-Aging Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. Competitive Landscape & Market Share Analysis 4.8. Impact of Covid-19 Analysis Chapter 5. Market Segmentation 1: by Precursor Estimates & Trend Analysis 5.1. by Precursor & Market Share, 2024 & 2034 5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Precursor: 5.2.1. Nicotinamide Riboside (NR) 5.2.2. Nicotinamide Mononucleotide (NMN) 5.2.3. Nicotinamide (NAM) 5.2.4. Nicotinic Acid 5.2.5. Tryptophan Chapter 6. Market Segmentation 1: by Product Type Estimates & Trend Analysis 6.1. by Product Type & Market Share, 2024 & 2034 6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product Type: 6.2.1. Supplements 6.2.1.1. Oral NAD Dietary Supplements 6.2.1.2. Topical NAD Supplements 6.2.1.2.1. Creams 6.2.1.2.2. Serums 6.2.1.2.3. Lip Creams 6.2.1.2.4. Eye Creams 6.2.2. Therapeutic Products 6.2.2.1. NAD injections/NAD IV 6.2.2.2. NAD Nasal Spray Chapter 7. Market Segmentation 3: by Type of Aging Estimates & Trend Analysis 7.1. by Type of Aging & Market Share, 2024 & 2034 7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Type of Aging: 7.2.1. Cellular Aging 7.2.2. Immune Aging 7.2.3. Metabolic Aging 7.2.4. Others Chapter 8. Market Segmentation 4: by Distribution Channel Estimates & Trend Analysis 8.1. by Distribution Channel & Market Share, 2024 & 2034 8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Distribution Channel: 8.2.1. Supermarkets & Hypermarkets 8.2.2. Specialty Stores 8.2.3. Convenience Stores 8.2.4. Pharmacies/Clinics 8.2.5. Online Stores Chapter 9. NAD-based Anti-Aging Market Segmentation 5: Regional Estimates & Trend Analysis 9.1. North America 9.1.1. North America NAD-based Anti-Aging Market Revenue (US$ Million) Estimates and Forecasts by Precursor, 2021-2034 9.1.2. North America NAD-based Anti-Aging Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034 9.1.3. North America NAD-based Anti-Aging Market Revenue (US$ Million) Estimates and Forecasts by Type of Aging, 2021-2034 9.1.4. North America NAD-based Anti-Aging Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034 9.1.5. North America NAD-based Anti-Aging Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 9.2. Europe 9.2.1. Europe NAD-based Anti-Aging Market Revenue (US$ Million) Estimates and Forecasts by Precursor, 2021-2034 9.2.2. Europe NAD-based Anti-Aging Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034 9.2.3. Europe NAD-based Anti-Aging Market Revenue (US$ Million) Estimates and Forecasts by Type of Aging, 2021-2034 9.2.4. Europe NAD-based Anti-Aging Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034 9.2.5. Europe NAD-based Anti-Aging Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 9.3. Asia Pacific 9.3.1. Asia Pacific NAD-based Anti-Aging Market Revenue (US$ Million) Estimates and Forecasts by Precursor, 2021-2034 9.3.2. Asia Pacific NAD-based Anti-Aging Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034 9.3.3. Asia Pacific NAD-based Anti-Aging Market Revenue (US$ Million) Estimates and Forecasts by Type of Aging, 2021-2034 9.3.4. Asia-Pacific NAD-based Anti-Aging Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034 9.3.5. Asia Pacific NAD-based Anti-Aging Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 9.4. Latin America 9.4.1. Asia Pacific NAD-based Anti-Aging Market Revenue (US$ Million) Estimates and Forecasts by Precursor, 2021-2034 9.4.2. Asia Pacific NAD-based Anti-Aging Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034 9.4.3. Latin America NAD-based Anti-Aging Market Revenue (US$ Million) Estimates and Forecasts by Type of Aging, 2021-2034 9.4.4. Latin America NAD-based Anti-Aging Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034 9.4.5. Latin America NAD-based Anti-Aging Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 9.5. Middle East & Africa 9.5.1. Middle East & Africa NAD-based Anti-Aging Market Revenue (US$ Million) Estimates and Forecasts by Precursor, 2021-2034 9.5.2. Middle East & Africa NAD-based Anti-Aging Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034 9.5.3. Middle East & Africa NAD-based Anti-Aging Market Revenue (US$ Million) Estimates and Forecasts by Type of Aging, 2021-2034 9.5.4. Middle East & Africa NAD-based Anti-Aging Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034 9.5.5. Middle East & Africa NAD-based Anti-Aging Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034 Chapter 10. Competitive Landscape 10.1. Major Mergers and Acquisitions/Strategic Alliances 10.2. Company Profiles 10.2.1. GenF20 Liposomal NMN 10.2.2. Wonderfeel 10.2.3. partiQlar Pure NMN 10.2.4. Tru Niagen 10.2.5. Elysium Health, Inc. 10.2.6. HPNSupplements 10.2.7. Life Extension 10.2.8. Nuchido 10.2.9. Decode Age 10.2.10. Codeage 10.2.11. NADIA Skin 10.2.12. Intuisse 10.2.13. Naderma Skincare 10.2.14. LifioLabs 10.2.15. RENUE BY SCIENCE, Inc. 10.2.16. FACIAL NOVA 10.2.17. Empower Pharmacy 10.2.18. RENUE BY SCIENCE, Inc. 10.2.19. AgelessRx 10.2.20. Empower Pharmacy 10.2.21. Galleria Medical Pharmacy 10.2.22. LG Household & Health Care, Ltd. 10.2.23. Bontac Bio-Engineering (Shenzhen) Co., Ltd 10.2.23. Other Market Players

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們